Arterial thrombo-embolic events in cardiac amyloidosis: a look beyond atrial fibrillation.
Francesco CappelliGiacomo TiniDomitilla RussoMichele EmdinAnnamaria Del FrancoGiuseppe VergaroGianluca Di BellaAnna MazzeoMarco CanepaMassimo VolpeFederico PerfettoCamillo AutoreCarlo Di MarioClaudio RapezziMaria Beatrice MusumeciPublished in: Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis (2020)
In our large, multicentric, real-world cohort, prevalence and incidence rate of AEs was high. A consistent proportion of events occurred despite anticoagulation therapy or in patients in sinus rhythm. A higher CHA2DS2-VASc score might identify patients at risk of AEs also among those in sinus rhythm.
Keyphrases
- atrial fibrillation
- left atrial
- oral anticoagulants
- catheter ablation
- end stage renal disease
- left atrial appendage
- risk factors
- direct oral anticoagulants
- ejection fraction
- newly diagnosed
- chronic kidney disease
- percutaneous coronary intervention
- heart rate
- left ventricular
- prognostic factors
- venous thromboembolism
- stem cells
- acute coronary syndrome
- cell therapy